1. Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment—Poor Prognosis or New Therapeutic Opportunity
   Lisa A. Ridnour et al, 2013, Clinical Cancer Research CrossRef
2. The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?
   Sebastian L. Hofbauer et al, 2016, Urologia Internationalis CrossRef
3. A retrospective analysis of patients treated with intravesical BCG for high-risk nonmuscle invasive bladder cancer
   Julie Mariam Joshua et al, 2019, Therapeutic Advances in Urology CrossRef
4. Toll‐like receptors: A pathway alluding to cancer control
   Ana Patricia Ayala‐Cuellar et al, 2019, Journal of Cellular Physiology CrossRef
5. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1
   Chao Yuan et al, 2015, Biochemical and Biophysical Research Communications CrossRef
6. Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice
   Andrés H. Rossi et al, 2015, PLOS ONE CrossRef
7. Interruption of BCG Therapy for NMIBC During COVID-19 Crisis, Dilemma in Its Continuation: a Review of Available Evidence and Suggested Management Strategies
   Jyoti Mohan Tosh et al, 2023, Indian Journal of Surgical Oncology CrossRef
8. Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model
   TAO YIN et al, 2015, Molecular Medicine Reports CrossRef
9. Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations
   Young Joon Moon et al, 2022, PLOS ONE CrossRef
10. Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis
    Francesco Del Giudice et al, 2023, Cancers CrossRef
11. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis
    Jiangang Pan et al, 2014, Frontiers of Medicine CrossRef
12. Treatment efficacy and tolerability of intravesical Bacillus Calmette-Guerin (BCG) - RIVM strain: induction and maintenance protocol in high grade and recurrent low grade non-muscle invasive bladder cancer (NMIBC)
    Naim B Farah et al, 2014, BMC Urology CrossRef
13. TLR4/IFNγ pathways induce tumor regression via NOS II-dependent NO and ROS production in murine breast cancer models
    Myriam Lamrani et al, 2016, OncoImmunology CrossRef
14. Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors
    Daniel Balan et al, 2018, Medicine CrossRef